Evidence supporting the use of: Vitamin E (alpha-tocopherol succinate)
For the health condition: Dementia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E, specifically in the form of alpha-tocopherol (and sometimes its succinate ester), has been investigated for its potential role in slowing the progression of dementia, particularly Alzheimer’s disease. The scientific rationale centers on Vitamin E's antioxidant properties, which may help counteract oxidative stress—a factor implicated in the neuronal damage seen in dementia. Several clinical trials have evaluated Vitamin E supplementation in patients with Alzheimer’s disease. Notably, a 1997 study published in the New England Journal of Medicine found that high-dose vitamin E (2,000 IU/day) modestly delayed functional decline in patients with moderate Alzheimer’s disease compared to placebo. A 2014 study in JAMA also reported a slower decline in daily functioning among Alzheimer’s patients receiving vitamin E, though cognitive outcomes were less clear. However, meta-analyses and systematic reviews have concluded that the overall evidence is mixed and the clinical benefits are modest at best. Concerns about potential risks, such as increased mortality with high-dose vitamin E, have also been raised. Major clinical guidelines do not recommend vitamin E as a primary treatment for dementia, though it may be considered in some cases. In summary, there is limited scientific evidence supporting vitamin E for dementia, with some studies indicating possible benefit but not enough to warrant routine use.

More about Vitamin E (alpha-tocopherol succinate)
More about Dementia

Products containing Vitamin E (alpha-tocopherol succinate)

We currently have no products on Vitabase that contain this ingredient.